查詢結果分析
相關文獻
- Prognostic Analysis in Patients of Lung Cancer with Brain Metastasis Under Surgical Removal
- Palliative Radiotherapy for Synchronous Brain Metastases from Lung Cancer
- Impact of Nutritional Status on the Survival of Lung Cancer Patients
- 小細胞型肺癌以鎝-99mMIBI胸部造影來評估化學治療反應與病人預後關係的初步報告
- 中西醫療法對肺癌病人預後之長期效益:個案配對研究
- Prognostic Factors Analysis of Lung Cancer Patients with Brain Metastasis after Whole Brain Irradiation
- Influence of Polymorphism at p53, CYP1A1 and GSTM1 Loci on p53 Mutation and Association of p53 Mutation with Prognosis in Lung Cancer
- Application of Array-Based Epigenomic Technology for the Identification of Hypermethylated CpG Site in Lung Cancer Patients
- Smoking History Associated with Specific Histology but Not Predicting the Prognosis of Non-small Cell Lung Cancer: Results from Chung Shan Medical University Hospital
- 初診斷肺癌病人接受手術期間經絡能量、生活品質變化與預後關聯性--縱貫性研究
頁籤選單縮合
題 名 | Prognostic Analysis in Patients of Lung Cancer with Brain Metastasis Under Surgical Removal=肺癌併腦轉移經開顱手術之預後評估 |
---|---|
作 者 | 黃旭霖; 洪純隆; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷 期 | 14:3 1998.03[民87.03] |
頁 次 | 頁126-131 |
分類號 | 416.291 |
關鍵詞 | 肺癌; 腦轉移瘤; 預後; 開顱手術; Prognosis; Lung cancer; Brain metastasis; |
語 文 | 英文(English) |
中文摘要 | 腦轉移瘤中以肺癌轉移最常見,保守療法的中間存活月數僅1至6個月,臺灣文獻中,5年存活率約為5%。本研究針對肺癌併腦轉移的患者,於開顱手術後的預後評估。從1985年6月至1992年5月共有33位患者,年齡為35歲至72歲 (平均56.4歲),包括21位男性,12位女性。以後評估因子有:年齡、性別、症狀發生的時間和表現,肺癌的部位和病理診斷,腦轉移的部位和數目,手術前和手術後的神經功能,顱部以外的身體轉移,手術後的放射線治療或化學治療以及存活月數。 三十三位患者平均存活月數為6個月 (從1個月至26個月),一年存活的比率為24%,大部份患者最後死因為呼吸衰竭。預後評估因子中以身體轉移 (P=0.0109),腦部放射線治療 (P=0.0121),以及肺部放射治療 (P=0.0361) 和預後最有關係。以Karnofsky評量法比較患者開顱手術前後之神經功能,統計學上可見積極手術明顯改善患者的神經功能 (P<0.001)。因此,對於肺癌併腦轉移的病患者,我們建議積極開顱手術再配合腦部和肺部放射線治療,不僅可以延長生命,也可以改善患者生活品質。 |
英文摘要 | The outcome and prognostic factor in postcraniotomy patients with brain metastasis from lung cancer in south Taiwan were evaluated. There were evaluated. There were 21 males and 12 females, with ages ranging from 35 to 72 years (mean, 56.4 years). The survival rate was determined from the date or craniotomy and was evaluated by the Kaplan-Meler product limit method. Iimit method. In the univariate analysis survival was significantly affected by systemic metastasis (P=0.0109), brain radiotherapy (P=0.0121) and chest radiotherapy (P=0.0361). Preoperative and postoperative Karnofaky scores were evaluated using the paired t-test and the neurological condition, as evaluated by Karnorsky scores, significantly improved after craniotomy (P<0.001). We concluded that an aggressive craniotomy and radiotherapy improves the quality of life and survival rate, especially in those patients with solitary brain metastasis and no extracranial metastasls. |
本系統中英文摘要資訊取自各篇刊載內容。